RANDAL J. KIRK - Director, 10%+ Owner at PRECIGEN, INC.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director, 10%+ Owner
Issuer Symbol
PGEN on Nasdaq
All Insider Reports
All Insider Reports

RANDAL J. KIRK - trading volume in the past year for PRECIGEN, INC.

Holdings reported by RANDAL J. KIRK for PRECIGEN, INC.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 81,609,648 $341,128,328 $4.18 22 Dec 2025 by R.J. Kirk DOT
Common Stock 14,597,161 $55,761,155 $3.82 22 Dec 2025 by Sunset 2020
Common Stock 6,085,471 $23,246,499 $3.82 22 Dec 2025 by Third Security
Common Stock 4,598,044 $19,219,823 $4.18 22 Dec 2025 by Kapital Joe
Common Stock 3,785,116 $15,821,784 $4.18 22 Dec 2025 by MGK 2009
Common Stock 3,609,057 $15,085,858 $4.18 22 Dec 2025 by JPK 2009
Common Stock 1,615,634 $6,753,350 $4.18 22 Dec 2025 by JPK 2012
Common Stock 1,594,338 $6,664,332 $4.18 22 Dec 2025 by MGK 2011
Common Stock 1,144,481 $4,371,917 $3.82 22 Dec 2025 by Spouse
Common Stock 1,096,686 $4,189,340 $3.82 22 Dec 2025 by Parkview 2020
Common Stock 566,162 $2,366,557 $4.18 22 Dec 2025 by ZSK 2008
Common Stock 477,492 $1,995,916 $4.18 22 Dec 2025 by JPK 2008
Common Stock 476,529 $1,991,891 $4.18 22 Dec 2025 by MGK 2008
Common Stock 447,773 $1,871,691 $4.18 22 Dec 2025 by Kellie L. Banks LTT
Common Stock 341,189 $1,426,170 $4.18 22 Dec 2025 by ZSK 2009
Common Stock 1,403 $5,359 $3.82 22 Dec 2025 by Lotus
Restricted Stock Units 0 $0 $1.74 14 Mar 2025 by R.J. Kirk DOT Common Stock
Warrant to Purchase Common Stock 16,666,667 30 Dec 2024 by R.J. Kirk DOT Common Stock
Option to Purchase Common Stock (Right to Buy) 167,034 13 Mar 2025 by R.J. Kirk DOT Common Stock
8.00% Series A Convertible Perpetual Preferred Stock 0 17 Sep 2025 by R.J. Kirk DOT Common Stock

Transactions reported by RANDAL J. KIRK for PRECIGEN, INC.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.